Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2020 | Genetic signatures & hereditary ATTR amyloidosis

Joel Buxbaum • 3 Sep 2020
ISA 2020
Amyloidosis Rare Diseases

Joel Buxbaum, MD, Scripps Research, La Jolla, CA, discusses in detail the genetic signatures associated with hereditary ATTR amyloidosis. Specifically discussed is how the pattern of penetrance of ATTR amyloidosis is dependant on a small number of genes (20-30 genes). Additionally, the genetic element relating to age-of-onset is also delineated. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Joel Buxbaum

5:43
Optimism for amyloidosis therapy
Joel Buxbaum • 3 Sep 2020
5:16
The evolution of AL amyloidosis therapy
Joel Buxbaum • 3 Sep 2020

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals